CV Sciences (CVSI) Asset Utilization Ratio (2013 - 2026)
CV Sciences' (CVSI) quarterly Asset Utilization Ratio came in at 1.96 in Q1 2026, little changed year-on-year from 1.95 in Q1 2025, and down 1.05% quarter-over-quarter from 1.98 in Q4 2025.
CV Sciences (CVSI) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Asset Utilization Ratio across 14 years of filings, most recently posting 1.96 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 1.96, changed 0.18% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.96 (changed 0.18% YoY), and the FY2025 annual result was 1.85, up 1.0% from the prior year.
- Asset Utilization Ratio came in at 1.96 for Q1 2026 at CV Sciences, down from 1.98 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.98 in Q4 2025 to a low of 1.08 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 1.8 (2024), against an average of 1.63.
- Across the five-year window, Asset Utilization Ratio jumped 57.87% in 2022 and rose 0.18% in 2026, its largest moves.
- CV Sciences' Asset Utilization Ratio stood at 1.16 in 2022, then soared by 46.32% to 1.7 in 2023, then advanced by 13.32% to 1.92 in 2024, then grew by 2.65% to 1.98 in 2025, then retreated by 1.05% to 1.96 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.96 (Q1 2026), 1.98 (Q4 2025), and 1.92 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.36 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.07 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.68 |
| 10 | CV Sciences | - | - | 1.56 Mn | 1.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.96 |
| Dec 31, 2025 | 1.98 |
| Sep 30, 2025 | 1.92 |
| Jun 30, 2025 | 1.91 |
| Mar 31, 2025 | 1.95 |
| Dec 31, 2024 | 1.92 |
| Sep 30, 2024 | 1.81 |
| Jun 30, 2024 | 1.83 |
| Mar 31, 2024 | 1.80 |
| Dec 31, 2023 | 1.70 |
| Sep 30, 2023 | 1.65 |
| Jun 30, 2023 | 1.47 |
| Mar 31, 2023 | 1.31 |
| Dec 31, 2022 | 1.16 |
| Sep 30, 2022 | 1.12 |
| Jun 30, 2022 | 1.10 |
| Mar 31, 2022 | 1.08 |
| Dec 31, 2021 | 0.96 |
| Sep 30, 2021 | 0.79 |
| Jun 30, 2021 | 0.71 |